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5-SASLThe direct interaction of the antibiotic primycin with the plasmamembrane was investigated by employing the
well-characterized ergosterol-producing, amphotericin B-sensitive parental Candida albicans strain 33erg+ and
its ergosterol-less amphotericin B-resistant plasma membrane mutant erg-2. The growth inhibition concentra-
tion in shaken liquid medium was 64 μg ml−1 for 33erg+ and 128 μg ml−1 for erg-2, suggesting that the plasma
membrane composition inﬂuences the mode of action of primycin. To determine the primycin-induced changes
in the plasma membrane dynamic, electron paramagnetic resonance (EPR) spectroscopy methods were used,
the spin-labeled fatty acid 5-(4,4-dimethyloxazolidine-N-oxyl)stearic acid) being applied for the in vivo mea-
surements. The phase transition temperatures of untreated strain 33erg+ and its mutant erg-2 were 12.5 °C
and 11 °C, respectively. After 128 μg ml−1 primycin treatment, these values increased to 17.5 °C and
16 °C, revealing a signiﬁcant reduction in the phospholipid ﬂexibility. Saturation transfer EPR measure-
ments demonstrated that, the rotational correlation times of the spin label molecule for the control samples
of 33erg+ and erg-2 were 60 ns and 100 ns. These correlation times gradually decreased on the addition of
increasing primycin concentrations, reaching 8 μs and 1 μs. The results indicate the plasma membrane
“rigidizing” effect of primycin, a feature that may stem from its ability to undergo complex formation
with membrane constituent fatty acid molecules, causing alterations in the structures of phospholipids
in the hydrophobic surface near the fatty acid chain region.ndida albicans; 5-SASL, 5-(4,4-
scopy, electron paramagnetic
y, saturation transfer electron
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The important human pathogen Candida albicans is a diploid di-
morphic unicellular yeast that has lost its sexual and parasexual cell
cycles. More than 50% of Candida infections and deaths are caused
by C. albicans [for reviews, see: [1–4]. Polyene antibiotics such as
amphotericin B (AmB) or nystatin, and azole compounds such as
miconazole or ﬂuconazole are generally used for the treatment
and prevention of systematic and superﬁcial mycoses. The leakage
of vital cell components and ions due to structural perturbation of
the plasma membrane has been described as one of the effects of
both types of antifungal drugs [5, 6]. In the case of AmB, this plasma
membrane damage is a consequence of additional complex formationwith fungal sterol molecules, the altered membrane permeability and
ion leakage possibly involving the formation of aqueous pores in special
experimental conditions consisting of an angulus of eight AmB mole-
cules with the membrane sterols [7, 8]. The occurrence of strains resis-
tant to both antibiotic families is very frequent, and in addition the
possibility of serious side-effects of these antibiotics may arise, such as
renal impairment [9, 10].
Primycin is a thermostable, absorptive, non-polyene macrolide lac-
tone with a broad antimicrobial spectrum [11, 12]. In contrast with the
above-mentioned antibiotics, its exact mode of action is not known so
far. It is effective against human pathogen G-positive and G-negative
bacteria, including polyresistant strains, and some yeasts and ﬁlamen-
tous fungi. The primycin sulfate-containing Ebrimycin® gel has been
successfully applied to prevent the bacterial infection of surface traumas
and burned tissues. It is effective against various microbes present in
destroyed skin, postoperative scabs and suppuration, bacterially infected
trophic ulcers, necrotic-based open ulcers and superfacial and deep
suppuration [12–14]. The selective loss of alkali metal cations from
primycin-treated erythrocytes was detected earlier [15]. The data
suggested that the direct point of attack of primycin antibiotic is the
plasma membrane. We have demonstrated an oleic acid–primycin
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Fig. 2. Conventional EPR-spectra of 5-SASL. The concentration-dependence of the
EPR spectra of 5-SASL incorporated in the plasma membrane of primycin-treated
(0–256 μg ml−1) strain 33erg+ of C. albicans at 20 °C is demonstrated. The spectral
parameter 2A′zz was deﬁned as the distance of the low-ﬁeld maximum and the
crossover point of the 5-SASL signal. The ﬁeld scan was 100 G.
43E. Virág et al. / Biochimica et Biophysica Acta 1818 (2012) 42–48interaction in vitro [16] suggesting unsaturated fatty acids of the
C. albicans plasma membrane as targets of primycin.
The high sensitivity of the spin-labeling electron paramagnetic
resonance (EPR) spectroscopy allows analysis of the primycin–plasma
membrane interaction. We utilized this technique to acquire informa-
tion relating to the nature and extent of the primycin–plasma mem-
brane interaction, using the ergosterol-producing strain 33erg+ of
C. albicans (a clinical isolate) and its ergosterol-deﬁcient plasma mem-
brane mutant erg-2.
2. Materials and methods
2.1. Chemicals
A stock solution (5 mgml−1) of the spin probe 5-SASL [5-(4,4-
dimethyloxazolidine-N-oxyl)stearic acid] was prepared in ethanol and
stored at −18 °C until use. Primycin (MW=1127.25, average mass)
was provided by the manufacturer (PannonPharma Ltd., Pécsvárad,
Hungary). The documentation indicated that, the content of active
agent in the sample was 865.03 U mg−1. Primycin consists of a mixture
of more than 20 derivates; a detailed description of the components
was reported by Virág et al. (2010). General structure of primycin and
the functional groups at the terminal positions can be seen in Fig. 6
and Table 1. Primycin was dissolved in dimethyl sulphoxide and
added to the cell suspensions in a ﬁnal concentration of 1% in each
case. All other chemicals were commercial products of analytical
grade from Sigma-Aldrich Ltd.
2.2. Strains and culturing conditions
Two eukaryotic model organisms were investigated: an adenine-
requiring ergosterol-producing C. albicans 33erg+ strain (ATCC 44829)
and its ergosterol-deﬁcient mutant erg-2 strain (ATCC 44831) [5,28].
The strains were cultured in YPD liquid medium (yeast extract 1%,
peptone 2%, glucose 2% and 50 μg ml−1 adenine at pH 6.5) or main-
tained on YPD medium supplemented with 2% agar. Mid-exponential
phase cultures were used. The growth inhibitory effect of primycin
was measured in liquid YPD cultures for 48 h at 30 °C on a shaker
operating at 150 rpm. The starting cell number was 106 cells ml−1;
cell numbers were determined spectrophotometrically (a Spectro-
nic® GenesysTM2 instrument) via the optical density at 595 nm.
The viability of parental strain was analyzed by streaking statio-
ner-phase cells on primycin containing minimal media (glucose 1%,0 10 20 30 40 50
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Fig. 1. Inhibition by primycin of the growth of the parental strain 33erg+ (A) and its plasma m
curves achieved the normal stationary phase at slower primycin concentrations, whereas
64 μg ml−1 and 128 μg ml−1 primycin, respectively. Primycin concentrations (μg ml−1): coagar 2%, (NH4)2SO4 0.5%, KH2PO4 0.1%, MgSO4 0.05%, vitamin solution
0.1%, 50 μg ml−1 adenine at pH 5.6).
2.3. Investigation of the viability and growth inhibition by primycin and
the primycin–ergosterol interaction
The viability of strain 33erg+ was investigated by determining the
number of colonies that rose after plating 500 cells on minimal media
contained 0, 150, 175, 200, 225 μl ml−1 primycin. Incubation of plates
carried out at 30 °C and the colonies were counted and controlled day
by day for 1 week. Growth inhibition by primycin was measured at
30 °C in shaken liquid media containing 0, 16, 24, 32, 64 or
128 μg ml−1 primycin, with initially 1×106 cells ml−1 Cells0 10 20 30 40 50
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embrane mutant erg-2 (B) of C. albicans. After cultivation for 40 h, the delayed growth
the multiplication of the cells of strains 33erg+ and erg-2 was blocked completely by
ntrol (□), 16 (▲), 24 (●), 32 (Y), 64 (a), 128 (▼).
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Fig. 3. Primycin concentration dependence of 2A′zz. Plots of 2A′zz at 20 °C as a function of incremental primycin concentration for strain 33erg+ (A) and its mutant erg-2 (B) of
C. albicans are shown. Data are the means±SD of three independent experiments.
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primycin–ergosterol interaction was measured as described by Virág
et al. (2010).
2.4. Preparation of samples for spin labeling
Mid-exponential phase cells were collected by centrifugation
(1071 g for 3 min) and washed twice with physiological salt solution.
For protoplast formation, the suspension was incubated for 90 min
with 2% lyophilized snail enzyme prepared from Helix pomatia and
0.2% lysing enzyme from Trichoderma harzianum in 0.6 M KCl as
osmotic stabilizer at 37 °C. In order to perform the spin labeling of plas-
ma membrane, cell-wall-free protoplasts were used. After incubation,
the protoplasts were washed twice in stabilizer solution and diluted
in 0.6 M KCl before the addition of spin probes [17]. Before spin-
labeling, the protoplasts were treated with 32, 64, 128 or 256 μg ml−1
primycin for 15 min. Suspensions were washed twice by centrifugation
at 3000 rpm for 5 min. A 3 μl aliquot of 5-SASL was added to a 500 μl of
suspension containing 1×108 protoplasts. The suspension was gently
shaken for 3 min at room temperature to facilitate spin probe incorpo-
ration. The protoplasts were sedimented and resuspended in 100 μl of
0.6 M KCl. The pH was 5.4 in each experiment. The suspension was59
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Fig. 4. Temperature dependence of 2A′zz. Plots of 2A′zz of the 5-SASL spin-labeled protoplas
are shown. The phase transition breakpoints (°C) are indicated. Conﬁdence interval of phas
mycin (■).placed in a 100 μl capillary tube and centrifuged again at 3000 rpm at
4 °C for 5 min. The supernatant was removed. Under these conditions,
no isotropic triplet arising from unincorporated spin probes was
detected [18].
2.5. EPR measurements
2.5.1. Conventional EPR measurements
EPR spectra were recorded with an ESP 300E spectrometer (Bruker
BioSpin, Germany) equipped with a diTC 2007 temperature regulator.
The accuracy of temperature measurement was±0.2 °C. The EPR spec-
tra of the membrane-incorporated fatty acid spin probe 5-SASL were
registered in the temperature range 0 to 30 °C [17]. The conventional
EPR spectra were obtained at a microwave power of 10 mW and a
ﬁeld modulation of 100 kHz with an amplitude of 2 G. The spectra
were scaled to the same peak-to-peak amplitude or were normalized
to an identical double integral. The spectra were characterized with
the hyperﬁne splitting constant (2A′zz), obtained from the conventional
EPR spectra, as the distance between the outermost extremes (Fig. 2).
The calculationwas performed by a computer algorithmdeveloped ear-
lier, based on a non-linear least squares method for ﬁtting [19-24].
Spectra were analyzed in terms of 2A′zz against reciprocal absolute2A
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ts of strain 33erg+ (A) and its mutant erg-2 (B) as a function of reciprocal temperature
e transition temperature: ± 1 °C. Symbols: control (□), treated with 128 μg ml−1 pri-
Fig. 5. ST-EPR spectra of 5-SASL. Representative ST-EPR spectra of the 5-SASL-labeled plasma membrane of the C. albicans 33erg+ protoplasts treated with 128 μg ml−1 (A) or
32 μg ml−1 (B) of primycin at 20 °C are demonstrated. To calculate the rotational correlation time of the probe molecules, the ratio of the peaks C′/C was determined.
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satisfactorily ﬁtted to a straight line.When an otherwise linear Arrhenius
plot exhibits a break, it suggests the existence of a phase change [25].
The problem of ﬁnding the possible breakpoint of two straight lines re-
quires the application of statistical methods [26]. A computer-assisted
procedurewas used to derive the breakpoint and to calculate the statis-
tical signiﬁcance of the difference between the slopes of the straight
lines. For all samples, our ﬁtting resulted in a better approximation to
two straight lines. This supports the suggestion of a phase change in
the membrane with increasing temperature.
2.5.2. Saturation transfer (ST)-EPR measurements
Second harmonic, 90° out-of-phase absorption spectra were
recorded at a microwave power of 63 mW and a ﬁeld modulation
of 50 kHz, with an amplitude of 5 G, the signals being detected at
100 kHz out-of-phase. The microwave power of 63 mW corresponds
to an average microwave ﬁeld amplitude of 0.25 G in the central re-
gion of a standard cavity. The values were obtained by using the
standard protocol of Fajer and Marsh (1982). The ratio of the cen-
tral-ﬁeld diagnostic peaks C′/C was used to obtain an estimate of
the rotational correlation time τc in the range 10−7 to 10−3 s of the
incorporated probe molecules [27].
3. Results and discussion
3.1. Primycin-induced growth inhibition and viability of strains
In all experiments, mid-exponential phase cultures of vegetative
cells or protoplasts of the C. albicans AmB-sensitive parental strain
33erg+ and its AmB-resistant strain erg-2 were used. In contrast
with the situation with AmB, neither lysis nor shrinking of primycin-Fig. 6. General structure of primycin. The possible combinations of R1 and R2 terminal
functional groups can be seen in Table 1.treated protoplasts was observed (data not presented). The absence of
ergosterol in the mutant erg-2 resulted in an increased accumulation
ofΔ8 sterols, a decreased fatty acid chain length and a lower proportion
of unsaturated fatty acids in the plasmamembrane in comparison with
the strain 33erg+ [5, 28]. The inhibition of the growth of the two strains
at the various primycin concentrations in shaken liquid media is illus-
trated in Fig. 1A and B. A given primycin concentration exerted signiﬁ-
cantly less inhibition on the mutant erg-2 than on its parental strain
33erg+. The dynamics of cell multiplication of both strains was slowed
by primycin in processes that proved to be concentration-dependent.
After cultivation for 40 h, the delayed growth curves achieved the nor-
mal stationary phase at primycin concentrations of 16, 24 and
32 μg ml−1, whereas the multiplication of the cells of strains 33erg+
and erg-2 was blocked completely by 64 μg ml−1 and 128 μg ml−1 pri-
mycin, respectively. No resistantmutants of human pathogenic Candida
spp. or clinical isolates of C. albicans have been found [14, 29].
The viability data reports about the retardation effect of primycin
on the cell multiplication, however the viability of survival colonies
remains the same during 1 week. Data reﬂects a concentration de-
pendent adaptation to primycin at a very low ratio (Table 2).
3.2. Interaction of primycin with plasma membrane: conventional EPR
measurements
The conventional EPR and the ST-EPR techniques cover the whole
range of interesting molecular motions in lipid and membrane systems
[27]. For the EPR measurements a spin label, the 5-SASL molecule, was
employed to monitor the near-surface hydrophobic region of the plas-
ma membrane. The hyperﬁne splitting constant 2A′zz is one of the pa-
rameters most commonly used to evaluate changes in membranes; it
can be derived from the EPR spectra. From the 2A′zz values, the correla-
tion time of the probe molecules can be estimated in the ns order of
magnitude. It characterizes the tumbling motion of the incorporated
molecules, and thereby reﬂects the “ﬂuidity” of the analyzed region. In
our experiments, the increase in 2A′zz as a function of increasing primy-
cin concentration indicated that the probemobility was decreasing. The
concentration-dependence of the hyperﬁne splitting constants at 20 °C
is demonstrated in Fig. 2. The plots of 2A′zz for strains 33erg+ and erg-2Table 1
The functional groups at the terminal positions of primycin.
A1 A2 A3 B1 B2 B3 C1 C2 C3
R1 a-D-arabinofuranosyl H H H OH OH OH
R2 butyl pentyl hexyl butyl pentyl hexyl butyl pentyl hexyl
The general structure of primycin can be seen in Fig. 6.
Table 2
Effectiveness of primycin on the viability of strain 33erg+.
Days Control 225 μg ml−1 200 μg ml−1 175 μg ml−1 150 μg ml−1
1 448 0 0 2 0
2 453 0 1 2 0
3 453 0 1 2 110
4 453 0 1 26 118
5 453 0 1 66 118
6 453 1 2 72 127
7 453 2 3 72 127
Number of colonies that rose after streaking 500 cells on primycin containing media.
Table 3
Values of C′/C and rotational correlation time of the 5-SASL of strains 33erg+ and erg-2
after treatment with various primycin concentrations (0–256 μg ml−1).
Primycin concentration (μg ml−1)
Strains 0 32 64 128 256
Ratio of the peaks, C′/C
33erg+ −1.30
(±0,1)
−0.64
(±0,03)
−0.23
(±0,03)
−0.17
(±0,01)
0.14
(±0,01)
erg-2 −0.91
(±0,03)
−0.7
(±0,02)
−0.5
(±0,02)
−0.6
(±0,03)
−0.6
(±0,04)
Rotational correlation time, τc 10−6s
33erg+ 0.06 0.5 3 4 8
erg-2 0.04 0.5 1 1 1
Data of C′/C are the means±SD of three independent experiments.
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data are the means of the results of three independent measurements,
with the standard deviations. Differences were detected in the angular
offset of the curves in the exponential phase for the two strains. Satura-
tion of the curves of 33erg+ and erg-2 started at primycin concen-
trations of 64 μg ml−1 and 256 μg ml−1, respectively, at which
concentrations the growth of these strains was fully blocked (Fig. 3A
and B). The increase in 2A′zz indicates that the mobility of the incorpo-
rated spin label molecules decreased in the monitored region of the
plasma membrane. This “rigidizing” effect of the primycin proved to
be concentration-dependent. The plot of 2A′zz against reciprocal tem-
perature exhibited a non-linear dependence; accordingly, a well-
deﬁned phase-transition temperature could be deduced (Fig. 4).
The phase-transition breakpoints of the untreated protoplasts of 33erg+
and erg-2were at 12.5 °C and 11 °C, respectively. Treatment of the proto-
plasts with 128 μg ml−1 primycin resulted in signiﬁcant increases of the
breakpoints of 33erg+ and erg-2, from 12.5 °C and 11 °C to 17.5 °C and
16 °C, respectively (Fig. 4A and B). These results showed that primycin
molecules are able to interact with the components of the plasmamem-
brane, and thereby to decrease the ﬂexibility of the lipid chains. In-
creased membrane rigidity was experienced in both strains, but the
phenomenonwasmore pronounced for themutant erg-2. It is notewor-
thy that, up to 28 °C, the distance between hyperﬁne splitting extremes
could be estimated without any difﬁculty with changing temperature.
At higher temperature, the intensities of both the inner and the outer
hyperﬁne splitting constants were no longer resolved, and the spectra
tended to become isotropic three-line EPR spectra. Themeasured differ-
ences in the plasma membrane parameters of the two strains might be
consequences of the adaptation induced by the altered sterol composi-
tion. The strain 33erg+ accumulates ergosterol (71.5%) and ergosta-7-
en-3β-ol (14.3%), while themutant erg-2membrane contains fecosterol
(55.6%) and zymosterol (42.7%) as themain sterols, indicating a block of
Δ8-Δ7 isomerase [28]. The ergosterol level in the plasma membrane of
yeast inﬂuences the membrane dynamics. For example, higher ergos-
terol levels led to a higher order parameter in the EPR spectra when
the 5-SASL spin probe was used [30], indicating a more ordered struc-
ture of themembrane [31]. The absence of ergosterol in erg-2 suggested
that ergosterol is not the main target of primycin [28]. In contrast to
AmB, no detectable interaction was measured between ergosterol and
primycin using the methods described earlier for the primycin-fatty
acid interaction (data not presented; [16]). In comparison with
33erg+, erg-2 contained lower amounts of phosphatidylcholine and
phosphatidylserine (described as ﬂuidizing lipids) and higher
amounts of phosphatidylinositol, phosphatidylethanolamine and
phosphatidic acid (considered to be rigidifying lipids) in themembrane
[28, 32]. However, the mutant erg-2 overcompensated the absence of
ergosterol, since the order parameter measured by EPR for the total
lipid extracts detected in lipid-water dispersions proved to be higher
for erg-2 than for 33erg+ (0.640±0.005 vs. 0.611±0.003) as a
consequence of the altered lipid composition of the mutant erg-2 [28].
The above data allowed the conclusion that the target molecules of pri-
mycin are located in the cell membrane.3.3. Interaction of primycinwith plasmamembrane: ST-EPRmeasurements
The ST-EPR spectra were analyzed in order to characterize the
effects of primycin treatment on the very slow molecular motions
in the phospholipid bilayer. The ST-EPR technique has proved very
useful for the determination of rotational correlation times (τc) be-
tween 10−7 and 10−3 s in physical and biological systems [22, 27,
33, 34]. In the ST-EPR spectra of 5-SASL, the ratio C′/C was analyzed
at 20 °C so as to estimate the value of τc [35]. Representative ST-
EPR spectra of the plasma membrane are to be seen in Fig. 5. The
estimated τc values of the lipid motions in the plasma membrane
of strains 33erg+ and erg-2 are presented in Table 3. The slower
correlation time indicates that the probe mobility decreased after
the primycin treatment, as a consequence of the primycin–lipid in-
teractions in the investigated region of the plasma membrane. The
correlation time of the incorporated 5-SASL molecule exhibited a non-
linear dependence above a primycin concentration of 64 μg ml−1. At
higher primycin concentrations, τc revealed signiﬁcantly less retarda-
tion, indicating saturation of the bulk of the primycin molecules in the
plasma membrane.
Determination of the ST-EPR spectra allowed calculation of the
probe molecule mobility in the order of magnitude of 10−6 s [35].
As a result of primycin treatment, the anisotropic rotation of the
spin label was changed. In the control plasma membrane, ST-EPR
spectroscopy indicated angular motion (τc≈10−6–10−8 s) and long
axis rotation (τc≈10−8–10−9 s) of the spin label. Primycin addition
eliminated this motion and the molecule displayed much slower mo-
tion. The data demonstrated the interesting phenomenon that the
correlation time for the liquid crystalline phase at room temperature
was of the order of magnitude of 10−9 s, as compared with 10−5 s
for the gel phase of the investigated plasma membrane systems. The
retardation of τc by approximately 1–1.5 orders of magnitude appears
to indicate the disorganization of the structure of the plasma mem-
brane. The fatty acid composition plays an important role in the mem-
brane ﬂuidization: a plasma membrane containing a higher level of
unsaturated fatty acids has a lower ﬂuidity [36]. Thus the differences
in sensitivity of the two strains to primycin might be based on their sig-
niﬁcantly different compositions of polyunsaturated fatty acids 16:2,
16:3 and 18:3 in the plasma membrane in the strains 33erg+ and
erg-2 (0.9 vs. 1.7, 2.2 vs 3.7,. 2.3 and vs 4.2%, respectively) [28]. The
interaction of oleic acid (comprising 35% of the fatty acids in C. albicans)
with primycin exhibited a complex character, based on the formation
of molecular complexes stabilized by one or two hydrogen-bonds).
In agreementwith this, it was recently reported that the interaction en-
ergies associated with these sites for one and two hydrogen-bonds
were −12.46 and −33.16 kJ mol−1, respectively [16]. New spatial
structures may be created by primycin-fatty acid complexes stabilized
by one or two hydrogen-bonds, the plasma membrane integrity being
destroyed in a primycin concentration-dependent manner, leading to
the loss of its barrier function [29].
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4.1. Conclusion of EPR measurements
Primycin is a water-insoluble and, lipid-soluble compound. Due to
these features primycin was able to get into the plasma membrane.
In the course of treatment the residual primycin molecules localized
in the extracellular space were cleared away by washing. It has
been proved that a part of the amount of primycin molecules inte-
grated in the plasma membrane has formed stable bounds with
certain membrane component compounds, likely with the fatty acid
molecules [16]. Furthermore we presumed that a certain amount of
primycin molecules was ﬁxated in the plasma membrane without
creating chemical bounds with membrane components and did not
left into the aqueous phase during the washing.
The following processes in the plasma membrane were taking
place inﬂuenced by primycin treatment: During the conventional
EPR measurements the characteristic spectra were of the spin-labeled
lipids received, giving information about the movement of spin label
with magnitude of ns correlation time that was ordered to an aniso-
tropic movement (the 2A′zz values were between 50 and 60 G). This
motion suggested that in the plasma membrane a phase, where the
label molecule had a free rotational diffusion existed (presumably it
was a layer closer to the cell surface). A saturation curve of 2A′zz
values was detected caused by enhancement of primycin concentra-
tion so the correlation time of the membrane probe decreased for
a while, and then it was jointed a constant value, referring to a ﬂexi-
bility developed in his phase of the membrane that was not become
reduced further by addition of many great primycin molecules.
The ST-EPR signal detected in the sample suggested that in the
plasma membrane another phase, where the correlation time of the
probe moved in microsecond scale, exists. This phase was in a region
where the bound with certain membrane compounds could be created
by primycin in the lipid bilayer (probably in the fatty acid region). If
the number of entered primycin molecules into the membrane-system
was increased, simultaneously the number of primycin molecules
being able to form chemical bounds also was enhanced, until free
binding sites for them was ﬁndable. The saturation was detected also
in this phase after a certain concentration. Presumably the primycin
added in “excess” was penetrated into the deeper region of plasma
membrane and passed into the cell. (Since the applied spin label pro-
vided information about the hydrophobic region of lipid bilayer near
surface, the effect evolved in the deeper region was not detectable.)
The phase transition temperature, investigated at a selected, inter-
mediate concentration, showed that the plasma membrane switched
off the gel phase to the ﬂuid phase at higher temperature, meaning
the membrane was stiffened by primycin that phenomenon was re-
lated to the above-mentioned chemical bonds formation of primycin
and membrane compounds.
Striking difference were between the saturation curves of parental
and mutant strains due to different membrane structure. The satura-
tion of the “membrane phase of nanosecond”was found at higher con-
centrations by the mutant strain indicating that more primycin
speciﬁc compounds was contained in the membrane at the “phase of
microsecond”. Previous literature data reports about that, the mem-
brane of erg-2 strain contained more polyunsaturated fatty acids that
were the assumed primycin binding compounds.
4.2. Conclusion of the mode of action of the antibiotic primycin
The direct interactions of the antibiotic primycin with the plasma
membrane of the pathogenic yeast C. albicans strain 33erg+ and its
plasma membrane mutant strain erg-2 (with a different membrane
composition) have been demonstrated for the ﬁrst time. These inter-
actions involve concentration-dependent complex “rigidizing” pro-
cesses as primycin treatment (i) increases the phase transitiontemperatures of both 5-SASL-labeled strains (this study), and (ii)
decreases the rotational correlation times measured by ST-EPR. The
absence of ergosterol–primycin interactions and the existence of
fatty acid–primycin interactions [this study; 16] strongly suggested
that steric alterations in the interacting molecules induced the
earlier-mentioned membrane perturbations rather than formation
of pores or channels as suggested in the case of AmB [8]. This
assumption may explain the fact that primycin interacts with all
types of microbial and animal cells [37].
The presented experimental items reﬂect a structural change in
the plasma membrane that investigation was designed knowing pre-
liminary studies on the action of primycin. The efﬂux of compounds
absorbing at 260 nm (nucleotides, nucleosides and free bases),
appearing to originate in the free intracellular pool of cells was recently
proved [29] and selective increases in the permeability of erythrocytes
to alkali cations according to the sequence: Cs+NRb+=K+≫Na+,
and leakage of Mg2+ were described [37, 38]. Furthermore the
other fallowing effects on membrane-associated processes were de-
ﬁned as action of primycin in bacteria and host cells: an increasing
conductance derived by selective efﬂux of ionswasmeasured in Bacillus
subtilis, red-blood cells and mitochondria [39, 40] In the case of neuro-
muscular neurons an increasing efﬂux of acetylcholine was demon-
strated, however there were a lacking data about the effect of primycin
directly on the ion channels [15, 37, 40–42]. Studies of Escherichia coli
reported about changes in the signal transduction system such as
an enhanced effect of primycin on activity of tyrosine aminotransferase
and blocking effect on RNA polymerase I. Primycin had inhibitory effect
on tryptophan pyrrolase and it stimulated the activity of tyrosine
aminotransferase in the liver cells of rats [11, 12, 43]. It should be
mentioned that the presented primycin-induced enzymatic changes
could come into existence as a pleiotropic physical effect via pertur-
bation of plasma membrane. Interaction of primycin molecules with
compounds of plasma membrane leads to the structural alteration
of membrane phases that consequence may be the destruction of
signal transduction systems and loss of function of membrane pro-
teins [44] - such as ion channels — rather than pore formation fea-
ture of primycin in plasma membrane.
The pharmaceutical signiﬁcance of our results is based on the
certiﬁcation of non-intracellular target of the drug with low potential
genetic mutation of pathogenic species. Hence application of primycin
in diseases associated opportunistic infectionswill have a big advantage
in the future because the adaptation to the drug showed a very low ratio
and no resistant strains was described.
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